Navigating Biotech’s New Normal, AI to Engineer Cas9 Enzymes, and Sequencing Generations

The seismic changes made by the current administration in the U.S. continue to impact the scientific community. Also, in honor of DNA Day, we reminisce about how the field has come since the discovery of the structure of DNA.The post Navigating Biotech’s New Normal, AI to Engineer Cas9 Enzymes, and Sequencing Generations appeared first on GEN - Genetic Engineering and Biotechnology News.

The seismic changes made by the current administration in the United States continue to impact the scientific community. The business news segment of this week’s episode covers the effects of job cuts on biotech, Roche’s manufacturing and R&D plans amid tariff threats, and shares an update on Eli Lilly’s diabetes pill. Also, in honor of DNA Day, we reminisce about how far the field has come since the discovery of the structure of DNA and the completion of the Human Genome Project.

We also talk about today’s DNA-related advances that use machine learning to design tailored Cas9 proteins, and multiple sequencing technologies to study mutation rates in four generations of the same family.Listed below are links to the GEN stories referenced in this episode of Touching Base:After Job Cuts, “We’re Entering a Very New Territory for BiotechBy Alex Philippidis, GEN Edge, April 17, 2025Roche Commits $50B to U.S.

Manufacturing, R&D as Tariffs LoomBy Alex Philippidis, GEN Edge, April 22, 2025StockWatch: Investors Hungry for Lilly after Diabetes Pill Aces Phase III TrialBy Alex Philippidis, GEN Edge, April 20, 2025Machine Learning Engineers Bespoke Cas9 Enzymes for Gene EditingBy Fay Lin, PhD, GEN, April 22, 2025Multi-Platform Sequencing Study of Four Generations Sheds Light on Mutation RatesGEN, April 23, 2025 Produced with support from:The post Navigating Biotech’s New Normal, AI to Engineer Cas9 Enzymes, and Sequencing Generations appeared first on GEN - Genetic Engineering and Biotechnology News..